-
EP3790425
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3790425
| EP3790425 - APPLICATOR AND SYSTEM FOR PHARMACEUTICAL PREPARATION AND METHOD OF USE [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 14.06.2024 Database last updated on 29.07.2024 | |
| Former | Request for examination was made Status updated on 12.02.2021 | ||
| Former | The international publication has been made Status updated on 16.11.2019 | Most recent event Tooltip | 26.06.2024 | New entry: Despatch of examination report + time limit | Applicant(s) | For all designated states Brickell Biotech, Inc. 5777 Central Avenue, Suite 102 Boulder, CO 80301 / US | [2021/11] | Inventor(s) | 01 /
BRINKMAN, Herbert 5777 Central Avenue Boulder, CO 90301 / US | 02 /
KOLENG, John 5777 Central Avenue Boulder, CO 90301 / US | 03 /
ALZENSTAT, Aron 5777 Central Avenue Boulder, CO 90301 / US | 04 /
SKLAWER, Andrew 5777 Central Avenue Boulder, CO 90301 / US | 05 /
NAGAO, Tatsuro 301 Gensuke Fujieda-shi, Shizuoka 426-8646 / JP | 06 /
TAKAOKA, Masayoshi 301 Gensuke Fujieda-shi, Shizuoka 426-8646 / JP | [2021/11] | Representative(s) | Thurgood, Alexander John IP GALORE Centre d'Affaires Amarante 3 bis rue Jean Bigot 63500 Issoire / FR | [2021/11] | Application number, filing date | 19799730.7 | 10.05.2019 | [2021/11] | WO2019US31876 | Priority number, date | JP20180092243 | 11.05.2018 Original published format: JP 2018092243 | US201862670475P | 11.05.2018 Original published format: US 201862670475 P | [2021/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019217926 | Date: | 14.11.2019 | Language: | EN | [2019/46] | Type: | A1 Application with search report | No.: | EP3790425 | Date: | 17.03.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.11.2019 takes the place of the publication of the European patent application. | [2021/11] | Search report(s) | International search report - published on: | US | 14.11.2019 | (Supplementary) European search report - dispatched on: | EP | 05.01.2022 | Classification | IPC: | A45D34/04, A45D40/26, A61M35/00, A61Q15/00 | [2021/11] | CPC: |
A45D34/04 (EP,IL,KR,US);
A61M35/003 (EP,IL,KR,US);
A45D40/26 (EP,IL,KR);
A61K31/23 (IL,KR);
A61K31/40 (EP,IL,KR,US);
A61K47/10 (EP,IL,KR);
A61K47/38 (EP,IL,KR);
A61K8/37 (EP,IL,KR);
A61K8/4913 (EP,IL,KR);
A61K9/0014 (EP,IL,KR,US);
A61K9/06 (EP,IL,KR);
A61M39/20 (IL,US);
A61P17/00 (EP,IL,KR);
A61Q15/00 (EP,IL,KR);
A45D2200/055 (EP,IL,KR);
A61K2800/87 (EP,IL,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/11] | Title | German: | APPLIKATOR UND SYSTEM FÜR PHARMAZEUTISCHE ZUBEREITUNG UND VERWENDUNGSVERFAHREN | [2021/11] | English: | APPLICATOR AND SYSTEM FOR PHARMACEUTICAL PREPARATION AND METHOD OF USE | [2021/11] | French: | APPLICATEUR ET SYSTÈME POUR PRÉPARATION PHARMACEUTIQUE ET PROCÉDÉ D'UTILISATION | [2021/11] | Entry into regional phase | 20.11.2020 | National basic fee paid | 20.11.2020 | Search fee paid | 20.11.2020 | Designation fee(s) paid | 20.11.2020 | Examination fee paid | Examination procedure | 20.11.2020 | Examination requested [2021/11] | 25.07.2022 | Amendment by applicant (claims and/or description) | 25.06.2024 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 14.04.2021 | Renewal fee patent year 03 | 28.04.2022 | Renewal fee patent year 04 | 26.05.2023 | Renewal fee patent year 05 | 27.05.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]US3874570 (KATZMAN STANLEY, et al); | [X]US2012220959 (BAYLY PETER [AU], et al) | International search | [XY]US3255481 (ADAMS DONALD R) [X] 53-56 * ; figures 1-3; column 1, lines 9-15, 20-22, 30-46 * [Y] 10, 38-41, 53-56; | [X]US3874570 (KATZMAN STANLEY, et al) [X] 1-7 * ; figures 1-4; column 2, lines 23-28 *; | [Y]US2008008671 (SCAVONE TIMOTHY A [US], et al) [Y] 35* ; paragraph [0015]; claim 13 *; | [Y]US2008207737 (ZINGER MENNI MENASHE [IL]) [Y] 33, 34, 37 * ; abstract; paragraph [0111] *; | [Y]US2011284579 (PARDES GREG [US], et al) [Y] 19-22 * ; figure 2; paragraph [0045] *; | [XY]US2012220959 (BAYLY PETER [AU], et al) [X] 1, 3, 6, 9, 12-17, 23, 25-26, 28, 30-32, 36 * ; figures 1, 2, 8; paragraphs [0009], [0025]-[0027], [0031], [0161], [0180]; claims 40, 48 * [Y] 10, 11, 18-22, 24, 27, 29, 33-35, 37,; | [Y]US2014221943 (CARRARA DARIO [CH], et al) [Y] 11, 18, 24, 27, 38-41, 53-56 * ; figures 1-2; paragraph [0078] *; | [Y] - "Sofpironium Dromidc Demonstrates Promising potential as a Sate and Effective First-Line Treatment for Primary Axillary Hyperhidrosis (Excessive Underarm Sweating", Business Wire, (20180220), URL: https://www.businesswire.com/news/home/20180220005502/en/Sofpironium-Bromide-Demonstrates-Promising-Potential-Safe-Effective, (20190708), XP055652781 [Y] 29 * ; title * |